Cytoskeletal autoantibodies/anti-actin antibodies

Christopher A. Aoki, Christopher Bowlus

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Anti-cytoskeleton antibodies were one of the first few autoantibodies to be discovered and have been found in a number of disease states. Further characterization of these autoantibodies has shown that these autoantibodies bind the principal components of microtubules, microfilaments, and intermediate filaments, which include actin, tubulin, keratin, vimentin, desmin, glial fibrillary acidic protein, peripherin, neurofilaments, alpha-internexin, and nuclear lamins. Because of their ubiquitous presence, cytoskeletal proteins are isolated from a number of different tissues and cells, and antibodies are detected using a variety of methods. Their significance is still under investigation but it has been suggested that they may be markers of ongoing tissue damage and non-specific B cell stimulation. Thus so far, the presence of anti-cytoskeletal antibodies has not been shown to be pathogenic and is of limited clinical utility. Although anti-cytoskeleton antibodies have been found in a number of diseases, none are pathognomic. In addition, most studies lack large numbers to determine an accurate sensitivity or specificity and therefore are not useful in clinical practice.

Original languageEnglish (US)
Title of host publicationAutoantibodies
PublisherElsevier Inc.
Pages309-316
Number of pages8
ISBN (Print)9780444527639
DOIs
StatePublished - 2007

Fingerprint

Autoantibodies
Actins
Anti-Idiotypic Antibodies
Intermediate Filaments
Cytoskeleton
Antibodies
Peripherins
Lamins
Cytoskeletal Proteins
Desmin
Glial Fibrillary Acidic Protein
Vimentin
Tubulin
Tissue
Keratins
Actin Cytoskeleton
Microtubules
B-Lymphocytes
Sensitivity and Specificity
Cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Cytoskeletal autoantibodies/anti-actin antibodies. / Aoki, Christopher A.; Bowlus, Christopher.

Autoantibodies. Elsevier Inc., 2007. p. 309-316.

Research output: Chapter in Book/Report/Conference proceedingChapter

Aoki, Christopher A. ; Bowlus, Christopher. / Cytoskeletal autoantibodies/anti-actin antibodies. Autoantibodies. Elsevier Inc., 2007. pp. 309-316
@inbook{b633ec1f2eb44db8adf07cdc24a389ba,
title = "Cytoskeletal autoantibodies/anti-actin antibodies",
abstract = "Anti-cytoskeleton antibodies were one of the first few autoantibodies to be discovered and have been found in a number of disease states. Further characterization of these autoantibodies has shown that these autoantibodies bind the principal components of microtubules, microfilaments, and intermediate filaments, which include actin, tubulin, keratin, vimentin, desmin, glial fibrillary acidic protein, peripherin, neurofilaments, alpha-internexin, and nuclear lamins. Because of their ubiquitous presence, cytoskeletal proteins are isolated from a number of different tissues and cells, and antibodies are detected using a variety of methods. Their significance is still under investigation but it has been suggested that they may be markers of ongoing tissue damage and non-specific B cell stimulation. Thus so far, the presence of anti-cytoskeletal antibodies has not been shown to be pathogenic and is of limited clinical utility. Although anti-cytoskeleton antibodies have been found in a number of diseases, none are pathognomic. In addition, most studies lack large numbers to determine an accurate sensitivity or specificity and therefore are not useful in clinical practice.",
author = "Aoki, {Christopher A.} and Christopher Bowlus",
year = "2007",
doi = "10.1016/B978-044452763-9/50045-7",
language = "English (US)",
isbn = "9780444527639",
pages = "309--316",
booktitle = "Autoantibodies",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cytoskeletal autoantibodies/anti-actin antibodies

AU - Aoki, Christopher A.

AU - Bowlus, Christopher

PY - 2007

Y1 - 2007

N2 - Anti-cytoskeleton antibodies were one of the first few autoantibodies to be discovered and have been found in a number of disease states. Further characterization of these autoantibodies has shown that these autoantibodies bind the principal components of microtubules, microfilaments, and intermediate filaments, which include actin, tubulin, keratin, vimentin, desmin, glial fibrillary acidic protein, peripherin, neurofilaments, alpha-internexin, and nuclear lamins. Because of their ubiquitous presence, cytoskeletal proteins are isolated from a number of different tissues and cells, and antibodies are detected using a variety of methods. Their significance is still under investigation but it has been suggested that they may be markers of ongoing tissue damage and non-specific B cell stimulation. Thus so far, the presence of anti-cytoskeletal antibodies has not been shown to be pathogenic and is of limited clinical utility. Although anti-cytoskeleton antibodies have been found in a number of diseases, none are pathognomic. In addition, most studies lack large numbers to determine an accurate sensitivity or specificity and therefore are not useful in clinical practice.

AB - Anti-cytoskeleton antibodies were one of the first few autoantibodies to be discovered and have been found in a number of disease states. Further characterization of these autoantibodies has shown that these autoantibodies bind the principal components of microtubules, microfilaments, and intermediate filaments, which include actin, tubulin, keratin, vimentin, desmin, glial fibrillary acidic protein, peripherin, neurofilaments, alpha-internexin, and nuclear lamins. Because of their ubiquitous presence, cytoskeletal proteins are isolated from a number of different tissues and cells, and antibodies are detected using a variety of methods. Their significance is still under investigation but it has been suggested that they may be markers of ongoing tissue damage and non-specific B cell stimulation. Thus so far, the presence of anti-cytoskeletal antibodies has not been shown to be pathogenic and is of limited clinical utility. Although anti-cytoskeleton antibodies have been found in a number of diseases, none are pathognomic. In addition, most studies lack large numbers to determine an accurate sensitivity or specificity and therefore are not useful in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84882556671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882556671&partnerID=8YFLogxK

U2 - 10.1016/B978-044452763-9/50045-7

DO - 10.1016/B978-044452763-9/50045-7

M3 - Chapter

AN - SCOPUS:84882556671

SN - 9780444527639

SP - 309

EP - 316

BT - Autoantibodies

PB - Elsevier Inc.

ER -